The bare lymphocyte syndrome is a disorder in which class I histocompatibility antigens fail to be expressed normally on the surface of lymphocytes. Utilizing complementary DNA probes for both #-microglobulin and class I genes, the molecular basis for this syndrome was investigated in a family with two siblings exhibiting the bare lymphocyte syndrome. Southern blot analysis demonstrated no gross internal defect in either class I or j2-microglobulin genes. Northern blot analysis of class I and ,B2-microglobulin messenger RNAs also revealed no qualitative difference between affected and unaffected family members. In contrast, quantitation of both class I and 2-microglobulin transcripts demonstrated each to be decreased in patients when compared to controls. Moreover, the decrease in both transcripts was coordinate. These results suggest that the bare lymphocyte syndrome may represent a pretranslational regulatory defect of both class I and #2-microglobulin gene expression.
Introduction
The bare lymphocyte syndrome is defined as a syndrome in which a patient's lymphocytes cannot be tissue-typed by standard serologic cytotoxicity tests. Touraine et al. (1) described a child presenting with severe combined immunodeficiency in the initial case report of 1978. Since then, several forms of the syndrome have been identified. A defect in class I major histocompatibility antigen expression has been described with and without concomitant severe combined immunodeficiency (2) (3) (4) (5) (6) (7) . Several case reports of a class II major histocompatibility defect have appeared recently. This class II defect may be isolated (8) or associated with a defect in class I expression (9-1 1) and has a variable phenotype. We have previously described two siblings without immunodeficiency who exhibit the bare lymphocyte syndrome. The older affected child presented in 1980 with aplastic anemia but had normal IgA, IgG, and IgM levels. The younger affected child has been healthy. Neither has suffered from any opportunistic infections nor an unusual number of viral infections (7) . Analysis of these patients may help clarify the factors involved in the regulation of cell surface expression of class I antigens and may contribute to our understanding of class I antigen functions. Here, for the first time is a demonstration of a pretranslational defect in both class I and ,B2-microglobulin gene expression associated with the bare lymphocyte syndrome.
Methods
Cells. Family "L," previously described (7) , was used as the sole source of "bare lymphocytes" for the experiments described. An affected child (AC2; see Fig. 1 (12) . The class I probe (gift of S. Weissman) is homologous to HLA B7 but crosshybridizes to HLA-A, -B, and -C genes (13) . The actin probe is a 1.5-kilobase (kb) cDNA clone (gift of P. Gunning) (14) . The gift of ribosomal cDNA was generated from L cells by Andree Dozy. RNA was isolated by the guanidinium method (15) . For the Northern blot in Fig. 2 -C, 25 ,g of total RNA was isolated from the EBV-transformed lines, denatured in formaldehyde as previously described (16, 17) , and applied to a 0.8% agarose gel. For the Northern blot in Fig. 5 , 5 ug of total RNA isolated from PBMCs was used. The gel was photographed using a silica thin-layer chromatography plate to identify the positions of the 18S and 28S bands. Blots were baked and incubated with a 50% formamide solution at 420C, as previously described (17) . 50 ng of probe, nick-translated to a specific activity of 108 cpm/ig was denatured by boiling and added to 10 ml of fresh formamide solution. After 24 h of incubation the blots were washed in 0.1 X standard saline citrate (pH 7.0), 0.1% sodium dodecyl sulfate (SDS) at 55°C as previously described (17) . Northern with the B7 probe, specific for class I antigens, a single band -1.7 kb in length was found for all family members (Fig. 2) . Therefore, it appears that neither the genes nor the transcripts for class I and 32-microglobulin are qualitatively abnormal in the bare lymphocyte syndrome. Quantitative analysis by Northern dot blots was undertaken in order to evaluate the levels of class I and j2-microglobulin transcripts in the circulating leukocytes from the affected and unaffected family members. 1 ug of total RNA isolated from the leukocytes of the family members was dotted onto nitrocellulose. This dot blot was then hybridized with either the class I, 02-microglobulin, or an actin control probe (Fig. 3) .
Class I and (2-microglobulin transcripts were found to be much lower by densitometry in the affected children than in the unaffected family members. Actin Leu 1,  phycoerythrin DR, and phycoerythrin M3), and the relative class I and f32-microglobulin density on the cells of each subpopulation was determined by using FITC-linked antibodies (Fig. 4) . In an affected child, class I and 12-microglobulin-specific fluorescence associated with the T cell Class I 18s
W. 0 population was 10.5-fold less than the mother or an unrelated control. Staining in the DR and M3 positive population was fourfold less in the affected child than in the control (Table I) . These findings suggest that not all cells are equally affected and that RNA levels might correspond more closely to surface expression if only affected cells are analyzed. When RNA from PBMCs, consisting of lymphocytes and monocytes, are analyzed by Northern blotting and densitometric scannings normalized to ribosomal (r)RNA levels, a 10-fold decrease of class I transcripts is seen in an affected child when compared to an unaffected family member (Fig. 5) Both class I and 132-microglobulin-specific transcripts were found to be decreased in the mononuclear cells of these affected children. Because these genes reside on chromosomes 6 and 15, respectively, and because EBV reverses the defect, it is unlikely that mutations in either gene could account for press only one-tenth the density of (2-microglobulin as the mother.
In the DR + and M3 population, the affected child's cells express approximately fourfold less B2-microglobulin than the unaffected mother.
our findings. Instead, it is likely that the bare lymphocyte syndrome represents a defect in the regulation of class I and j32-microglobulin gene expression. A related syndrome with a class II defect is also thought to represent a defect in regulation (9) . That these genes share common regulatory pathways is suggested by the finding that they are coordinately expressed in development. Class I and #2-microglobulin antigens are absent from fertilized mouse eggs but appear later in development (25, 26) . This developmental control is reproduced in embryonal carcinoma cells (27) . Embryonal carcinoma cells do not express class I antigens on their surface nor do they have detectable levels of transcript for either gene (28) (29) (30) , Differentiation of these cells is accompanied by coordinate accumulation of messenger RNAs and surface expression of class I molecules (27) . From these experiments, it is clear that class I and #2 microglobulin genes are simultaneously induced during development. (37) , and it is possible that they exist for class I histocompatibility genes. The low levels of class I and /2-microglobulin transcripts, which are found in the lymphocytes of our patients, may be products of a constitutive pathway unaffected by the absence of a regulatory protein. This constitutive pathway may also account for the normal levels of class I and /32-microglobulin found on our patients platelets.
The levels of class I and /2 microglobulin transcripts in the bare lymphocytes were 10-fold lower than in normal controls. The levels of surface class I molecules were from 4-to 10-fold diminished when affected and unaffected family members were compared. Actin levels were slightly decreased compared to controls and this may reflect altered metabolism in these cells. Therefore, a pretranslational defect in class I and /32-microglobulin certainly constitutes a major factor in the bare lymphocyte syndrome, but at this time we are not able to rule out other effects. It should be stressed that the defect observed in this family with the bare lymphocyte syndrome without immunodeficiency may not reflect that found in other cases of the bare lymphocyte syndrome with immunodeficiency. Only through further study of this and similar disorders will the true nature of the bare lymphocyte syndrome defect be revealed and therapeutic intervention become possible.
